Artem Andrianov, Managing Director at Cyntegrity, Beat Widler, Managing Partner at Widler & Schiemann and María Proupín-Pérez, Project Leader at PPH plus interpret the new ICH E6 addendum’s implication on Clinical Development. Risk Management, Quality Management, Risk-based Monitoring and CRO oversight are the main topics. Read more at:
Read more online